Trio’s tech-enabled solution offers both retrospective data and prospective data collection, and real-time patient surveillance. We help you to understand real-world clinical performance and identify opportunities for improvement.
Better understand safety and improve pharmacovigilance
Our Competitive Advantage
Ability to monitor real-world drug usage and safety in real-time
Direct EMR access to identify unmet patient needs at the physician/practice level
Access to the physician and patient voice to understand the why behind treatment decisions
Scientific Steering Committees (SSCs) comprised of highly respected, disease-specific key opinion leaders (KOLs) to identify key research trends to support innovative study designs
Linking data via Datavant Tokens to supplement data and insights
.png?width=800&height=400&name=WHITE%20CIIC%20LOGO%20(1).png)
.png?width=500&height=250&name=WHITE%20CIIC%20LOGO%20(1).png)
.png?width=270&height=505&name=Untitled%20design%20(10).png "categories of trio health publications. clinical outcomes, patient voice, treatment safety, market access and payer strategy, linking via datavant token")
.png?width=851&height=505&name=Query%20of%20the%20Trio%20database%20is%20conducted%20using%20the%20clinical%20protocol.%20Real-world%20patients%20who%20meet%20the%20criteria%20are%20collected%2c%20and%20their%20treating%20physicians%20are%20identified.%20(7).png "200+ peer reviewed publications since inception. 125+ clinical, 45+ patient voice, 20+ access to care, 10+ safety")
